AbbVie Inc. (4AB.DE) Stock Price
€183 0.1%
to add to portfolio
AI Score
-
Alternative
6 -
Fundamental
4 -
Technical
7
Our AI score evaluates a company's performance on a scale from 0 to 10 by analyzing alternative data points — web traffic, app downloads, job postings, etc - along with financial health and technical signals. Scores below 4 project bearish performance, while scores above 6 project bullish performance.
Sign up to get access to more historical data and insights on AbbVie Inc., AI stock picks, stock alerts and much more.
4AB.DE AI Stock Analysis
AI stock analysis for 4AB.DE is missing at the moment.
Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like AbbVie Inc. (4AB.DE) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.
Sign up and become a member to get access to AI stock analysis.
Sign up
AbbVie Inc. (4AB.DE) Price Prediction
Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of AbbVie Inc. (4AB.DE), currently trading at €183, will... Sign up to access price prediction.
Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.
About 4AB.DE
-
AbbVie Inc.
-
Symbol
4AB.DE
-
Market
XETRA
-
Industry
Drug Manufacturers - General
-
Market Cap
322.2B
Similar Stocks
 |
Pfizer Inc. PFE.F |
€24.88 2.6% |
5 |
 |
Amgen Inc. AMG.DE |
€278.7 0.6% |
6 |
 |
AstraZeneca PLC ZEG.DE |
€133.8 2.1% |
6 |
 |
Pfizer Inc. PFE.DE |
€24.87 2.9% |
4 |
 |
Biogen Inc. IDP.DE |
€138 0.8% |
5 |
News
4AB.DE Alternative Data
Web Traffic
AbbVie Inc. receives an estimated 1.1M monthly visitors to abbvie.com.
-
Web Traffic
1129310
-
Change from Previous Month
11.8%
-
3 Month Change
18%
News Mentions
AbbVie Inc. was mentioned 2 times in the news yesterday.
-
News Mentions
2
-
Daily Change
0%
-
1 Month Change
66.7%
-
3 Month Change
50%
Twitter Followers
AbbVie Inc. has 79,296 Twitter Followers on its main Twitter (also known as X) account, which is down by -0.3% over the last month.
-
Twitter Followers
79296
-
Daily Change
0%
-
1 Month Change
0.3%
-
3 Month Change
0.9%
TikTok Followers
-
TikTok Followers
3746
-
Daily Change
0%
-
1 Month Change
1.1%
-
3 Month Change
37.4%
Facebook Engagement
AbbVie Inc. has engaged 102 users via their Facebook Page over the last 7 days.
-
Facebook Engagement
102
-
Daily Change
22.1%
-
1 Month Change
86.4%
-
3 Month Change
57.5%
Instagram Followers
AbbVie Inc. has 39,619 Instagram Followers on its main Instagram account, up by 0.9% over the last month.
-
Instagram Followers
39619
-
Daily Change
0%
-
1 Month Change
0.9%
-
3 Month Change
3.4%
Youtube Subscribers
AbbVie Inc. has 6,760 subscribers on its main Youtube channel, up by 1.2% over the last month.
-
Youtube Subscribers
6760
-
Daily Change
0%
-
1 Month Change
1.2%
-
3 Month Change
4%
LinkedIn Followers
1,505,049 are following AbbVie Inc. on LinkedIn, up by 1.4% over the last month.
-
LinkedIn Followers
1505049
-
Daily Change
0.1%
-
1 Month Change
1.4%
-
3 Month Change
3.8%
Job Postings
AbbVie Inc. currenly has an estimated 1,000 open job postings.
-
Job Postings
1000
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
LinkedIn Employees
According to LinkedIn, AbbVie Inc. has 53,931 employees, down by -1.6% over the last month.
-
LinkedIn Employees
53931
-
Daily Change
0%
-
1 Month Change
1.6%
-
3 Month Change
4.1%
App Downloads
-
App Downloads
2
-
Daily Change
0%
Business Outlook
-
Business Outlook
78
-
Change from Previous Month
0%
-
3 Month Change
0%
-
YoY Change
0%
4AB.DE Financials
4AB.DE Key Metrics
-
Total Revenue
$14.5B
-
Net Income
$1.6B
-
Earnings per Share
$0.88
-
Free cash flow
$5.2B
-
EBITDA
$4.9B
-
EBITDA Ratio
0.33769
-
Total Assets
$143.4B
4AB.DE 2-year Revenue & Income
4AB.DE 2-year Free Cash Flow
4AB.DE Technicals
4AB.DE SMA
4AB.DE RSI
FAQ
What's the current price of AbbVie Inc. (4AB.DE) Stock?
The price of an AbbVie Inc. (4AB.DE) share is €183.
What's the market cap of AbbVie Inc.?
The current market cap of AbbVie Inc. is 322.2B.
Should I buy or sell 4AB.DE?
AbbVie Inc. shows several positive indicators, but they aren’t strong enough to warrant a buy recommendation. At its current price, AbbVie Inc. is better viewed as a hold or accumulate position while waiting for further developments.
Is AbbVie Inc. a good investment?
The current analysis of AbbVie Inc.'s fundamentals, technical aspects, and alternative data insights indicates a neutral outlook on the stock. While there are promising elements in AbbVie Inc.'s portfolio, the presence of equal risks and opportunities suggests that it might not drive significant gains or losses at this moment.
Is now a good time to buy AbbVie Inc. (4AB.DE) Stock?
Based on an analysis that includes fundamentals, technical analysis, and alternative data insights, the outlook for AbbVie Inc. stock is currently neutral, suggesting a cautious approach might be wise.
What are some stocks similar to AbbVie Inc. (4AB.DE) that investors often compare it to?
AbbVie Inc. (4AB.DE) is often compared to similar stocks such as Pfizer Inc., Amgen Inc., AstraZeneca PLC, Pfizer Inc. and Biogen Inc..
What is the forecast for AbbVie Inc.'s stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast AbbVie Inc.'s stock price to be around €189.2 in 2026. Starting from the current price of €183, this represents a 3.4% change in price, indicating a neutral outlook for the stock.
How to buy AbbVie Inc. (4AB.DE) Stock?
AbbVie Inc. stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy AbbVie Inc. shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.